Schizophrenia Patients: Clinical Trials

11 trials for Schizophrenia Patients, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 4 not yet recruiting, 1 active not recruiting, 1 recruiting. 7 Not applicable, 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable7Not yet recruiting 3, Completed 2, Active not recruiting 1, Recruiting 1
Phase 12Completed 2
Phase 21Completed 1

Follow Schizophrenia Patients: new trials by email Literature Review of Schizophrenia Patients trials Research Report on Schizophrenia Patients

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Cognitive Behavioral Therapy on Auditory Hallucinations and NLR in Schizophrenia Patients
Cognitive Behavioral Therapy (CBT), risperidone - Schizophrenia Patients, Auditory Hallucination
Not applicableCompletedHasanuddin University502025-11-012026-04-17
Effectiveness of Ashwagandha in Schizophrenia Patients on Risperidone
Risperidone 4mg/day, Ashwagandha, Placebo - Schizophrenia Patients, Neuroinflammation
Phase 2CompletedHasanuddin University802025-10-012026-05-12
Combined Exercise and PMS: Impact on Biopsychosocial Function in Older Adults With Schizophrenia
Peripheral Magnetic Stimulation (PMS), ham control group receiving PMS intervention, Exercise - Schizophrenia Patients
Not applicableNot yet recruitingYuntong Zhang402025-09-282025-09-26
Effect of Ashwagandha as Adjunct Therapy on BDNF and Cognitive Function in Schizophrenia Patients
Risperidone 4mg/day, Ashwagandha, Placebo - Schizophrenia Patients
Not applicableCompletedHasanuddin University802025-09-012026-04-23
ACT-Based Psychoeducation for Schizophrenia Caregivers
ACT-based psychoeducation - Schizophrenia Patients
Not applicableNot yet recruitingAtaturk University342025-07-072025-05-14
Video Game-facilitated Group Activity for Quality of Life and Social Function in Chronic Schizophrenia Inpatients.
Video game-facilitated group activity - Schizophrenia Patients
Not applicableActive not recruitingTsaoTun Psychiatric Center, Department of Health, Taiwan642025-05-032025-08-29
The Effect of Psychosocial Skills Focused Group Psychoeducation in Schizophrenia Patients
psychosocial skills-oriented group psychoeducation - Schizophrenia Patients, Psychoeducation
Not applicableNot yet recruitingGazi University342025-04-152025-03-12
Intermittent Theta-Burst Stimulation to Improve Negative Symptoms and Cognition in Schizophrenia
Intermittent theta-burst stimulation, Sham intermittent theta-burst stimulation - Schizophrenia Patients
Not applicableRecruitingHannover Medical School602025-04-082026-09-18
Effects of Lurasidone on Left Ventricle Systolic Functions
Global Longitudinal Strain - Lurasidone Cardiotoxicity, Schizophrenia Patients
Not yet recruitingAydin Adnan Menderes University622024-11-012024-11-19
Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients
Paliperidone Palmitate - Schizophrenia Patients
Phase 1CompletedLuye Pharma Group Ltd.362020-01-222020-11-09
Midazolam Drug-Drug Interaction Study With Lurasidone HCl
Lurasidone HCl - Schizophrenia Patients
Phase 1CompletedSumitomo Pharma America, Inc.242008-10-012011-09-08

Narrower conditions

Schizophrenia (5)  ·  Inflammation (2)  ·  Bipolar Disorder (1)  ·  Cardiotoxicity (1)  ·  Hallucinations (1)  ·  Neuroinflammatory Diseases (1)  ·  Psychological Well-Being (1)  ·  Social Adjustment (1)  ·  Treatment Adherence and Compliance (1)

Broader conditions

Mental Disorders (6)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (5)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Behavior (2)  ·  Nervous System Diseases (2)  ·  Bipolar and Related Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Health Behavior (1)  ·  Heart Diseases (1)  ·  Mood Disorders (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)

Interventions

Risperidone (3)  ·  Ashwagandha (2)  ·  Antipsychotic Agents (1)  ·  Cognitive Behavioral Therapy (1)  ·  Exercise (1)  ·  Global Longitudinal Strain (1)  ·  Lurasidone Hydrochloride (1)  ·  Paliperidone Palmitate (1)

Sponsors

Hasanuddin University (3)  ·  Ataturk University (1)  ·  Aydin Adnan Menderes University (1)  ·  Gazi University (1)  ·  Hannover Medical School (1)  ·  Luye Pharma Group Ltd. (1)  ·  Sumitomo Pharma America, Inc. (1)  ·  TsaoTun Psychiatric Center, Department of Health, Taiwan (1)  ·  Yuntong Zhang (1)

Countries

Indonesia (3)  ·  Turkey (Türkiye) (2)  ·  United States (2)  ·  Germany (1)  ·  Taiwan (1)

Top investigators

Marina Bussel, MD (1)  ·  Masnaeni Awaliah, MD (1)  ·  Rina Nurul Qalbi, MD (1)  ·  Yung-Jen Yang (1)

Results publications

PMID 42630304, PMID 42752599